However, the compound has not demonstrated significant intrinsic cytotoxic effects on any of the tested human colon cancer cells and has not been found to sensitize cells to doxorubicin, indicating that efflux by ABCB1 is not the only mechanism of resistance in these cells. This evidence concerns the gene ABCB1 and colonic neoplasm.